|
⚲
|
| Keyboard |
| Adams Kendra
✚
|
|
|---|---|
| CIK # | 0001991929 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001991929] | |
| 4 | [0001991929] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Adams Kendra | |
| C4 Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
C4 Therapeutics Inc CCCC
Common Stock
|
2026-02-14 | Tax withheld | 15,381 | $1.89 | 29,070 |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2026-02-14 | Option exercise | 30,950 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2026-02-13 | Tax withheld | 1,863 | $1.89 | 3,521 |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2026-02-13 | Grant | 240,000 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2026-02-13 | Option exercise | 3,750 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Stock Option (Right to Buy) · derivative
|
2025-02-14 | Grant | 130,600 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2025-02-14 | Tax withheld | 4,559 | $3.18 | 14,498 |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2025-02-14 | Grant | 87,100 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2025-02-13 | Tax withheld | 1,863 | $3.20 | 5,962 |
|
C4 Therapeutics Inc CCCC
Performance Restricted Stock Units · derivative
|
2024-11-07 | Option exercise | 3,750 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2024-11-07 | Option exercise | 3,750 | ||
|
C4 Therapeutics Inc CCCC
Common Stock
|
2024-11-07 | Tax withheld | 1,102 | $6.04 | 6,656 |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2024-09-18 | Tax withheld | 1,837 | $6.38 | 11,720 |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2024-09-16 | Tax withheld | 661 | $6.36 | 4,204 |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2024-09-16 | Option exercise | 2,250 | ||
|
C4 Therapeutics Inc CCCC
Performance Restricted Stock Units · derivative
|
2024-09-16 | Option exercise | 2,250 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Stock Option (Right to Buy) · derivative
|
2024-03-07 | Grant | 45,000 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Stock Option (Right to Buy) · derivative
|
2024-03-07 | Disposed to issuer | 45,000 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2024-02-14 | Grant | 36,700 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Stock Option (Right to Buy) · derivative
|
2024-02-14 | Grant | 165,300 | $0.00 | |
| showing 20 of 23 most recent transactions | |||||